Navigation Links
FDA Revokes Approval of Avastin for Breast Cancer
Date:11/21/2011

By Steven Reinberg
HealthDay Reporter

FRIDAY, Nov. 18 (HealthDay News) -- Saying the risks outweigh the benefits in patients with advanced breast cancer, U.S. Food and Drug Administration Commissioner Dr. Margaret Hamburg said on Friday that the agency has rescinded its approval of the cancer drug Avastin for that use.

Avastin (bevacizumab), however, will remain available for treating some types of colon, lung, kidney and brain cancer.

"Today, I am revoking the FDA's approval of the breast cancer indication for Avastin after concluding that the drug has not been shown to be safe and effective for that use," Hamburg said during a late morning press conference.

"Sometimes, despite the hopes of investigators, patients, industry, and even the FDA, the results of rigorous testing can be disappointing," she said. "This is the case with Avastin when used for the treatment of metastatic breast cancer."

The risks of Avastin include severe high blood pressure, bleeding, heart attack or heart failure and the development of perforations in different parts of the body such as the nose, stomach and intestines.

"These are considerable risks from taking Avastin, and can be justified only if there is good evidence that the use of the drug will benefit the patient," Hamburg said. "In breast cancer, it was clear that there was no proof of benefits that would justify the risks."

The FDA's decision was based on an expert panel's unanimous recommendation in June that the drug was not safe or effective when used for women with metastatic breast cancer. The drug had been approved for use along with the cancer drug Taxol (paclitaxel) for an aggressive type of breast cancer called HER2-negative breast cancer.

In 2008, Avastin was approved to treat metastatic breast cancer under the FDA's accelerated approval program, Hamburg said. Under this program, a drug can gain approval before final data on its safety
'/>"/>

Copyright©2010 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3 4

Related medicine news :

1. St. Michaels echocardiology lab awarded international seal of approval
2. Mayo Clinic receives FDA approval for ovarian and breast cancer vaccines
3. Pioneering stem cell bandage receives approval for clinical trial
4. FDA predictability a top concern for medtech firms; EU preferred for product approval
5. New Hepatitis C Drugs Close to Gaining FDA Approval
6. New Hepatitis C Drug Close to Gaining FDA Approval
7. Sanofi Pasteur announces FDA approval of menactra meningococcal conjugate vaccine indication for infants
8. FDA approval of brain aneurysm device gives Jefferson neurosurgeons another life-saving tool
9. Novel immunotherapy drug receives FDA approval for the treatment of metastatic melanoma
10. Speedy generic approval may not benefit consumers as much as expected, Rotman model shows
11. Speedy generic approval may not benefit consumers as much as expected, Rotman model shows
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
FDA Revokes Approval of Avastin for Breast Cancer
(Date:10/20/2014)... Florida (PRWEB) October 20, 2014 With ... former Gov. Charlie Crist made a brief fundraising stop ... Orlando on Thursday. , Fresh from a debate last ... to take the stage for the first seven minutes ... the former governor described the incident in one word: ...
(Date:10/20/2014)... T.E.N., a technology and information security ... William H. Murray, renowned author and industry visionary, ... Award winner. Presented annually, the ISE® Luminary Leadership ... and industry practitioner for his or her distinguished ... security industry. , Formerly with IBM, Murray is ...
(Date:10/20/2014)... Dunbridge, Ohio (PRWEB) October 20, 2014 ... 50 years, takes pride in manufacturing top-of-the-line absorbent products. ... the image of its most popular brand, Tranquility® Premium ... logo, created a new website, gave its packaging a ... to bring the brand message to the public. , ...
(Date:10/20/2014)... Collins, CO (PRWEB) October 20, 2014 ... dGH assays are the only imaging assays capable ... in a single test.  With these three dimensions ... their ability to detect the widest range of ... translocations—mutations usually missed by other genomic tools, including ...
(Date:10/20/2014)... (PRWEB) October 20, 2014 Punzoné , ... in the U.S., has a lot to celebrate this month. ... country recognizes the achievements and contributions of Americans of Italian ... for Punzoné, and today it shares its favorite Italian cocktails ... trip to Italy - even if it is only in ...
Breaking Medicine News(10 mins):Health News:At Crist Fundraiser, Dan Newlin Says, "No More Robert Germans," Will Seek Changes to Florida Missing Persons Law 2Health News:At Crist Fundraiser, Dan Newlin Says, "No More Robert Germans," Will Seek Changes to Florida Missing Persons Law 3Health News:Bill Murray named 2014 ISE® Luminary Leadership Award Winner 2Health News:Bill Murray named 2014 ISE® Luminary Leadership Award Winner 3Health News:Bill Murray named 2014 ISE® Luminary Leadership Award Winner 4Health News:Tranquility® Premium Protection Incontinence Products Releases New Logo and Website 2Health News:KromaTiD Launches Genome Screening and Discovery Services 2Health News:KromaTiD Launches Genome Screening and Discovery Services 3Health News:Celebrate Italian Heritage Month With Authentic Cocktails from Punzoné: The Only Ultra Premium Line of Organic Imported Italian Vodka 2Health News:Celebrate Italian Heritage Month With Authentic Cocktails from Punzoné: The Only Ultra Premium Line of Organic Imported Italian Vodka 3Health News:Celebrate Italian Heritage Month With Authentic Cocktails from Punzoné: The Only Ultra Premium Line of Organic Imported Italian Vodka 4
... opinion that dairy products provide the necessary dietary calcium ... on collected information available that relates to growth of ... products show little or no relationship between the two., ... to 1500mg of calcium for their bone development. Taking ...
... eating onions may be the key to avoid the risk ... compound in onions, a peptide called GPCS that seems to ... bone cells of newborn mice that were treated with parathyroid ... later exposed to the peptide GPCS. The treatment with the ...
... aureus (MRSA) infection is affecting people// who before had ... interviewing patients with MRSA infections, and reviewing their medical ... are acquired from the community. The rate of being ... below two years old than among those who are ...
... out that excessive exposure to television at the early childhood ... ,A child is considered to be a bully when he ... by actual physical attack on others or by verbal assaults, ... aloud to their children, or provide them with emotional support, ...
... made a study of the genomic sequence of human X ... ,The IOB analysis showed that the human X chromosome ... novel protein-coding regions and 696 known genes. The researchers ... of pseudogenes on X chromosome. The study found 652 pseudogenes ...
... out effective treatment for patients having pain due osteoarthritis in one ... one full Lidoderm patch in the front of the knee and ... study result showed that after six weeks of treatment majority of ... pain relief or more. To the other group the treatment was ...
Cached Medicine News:
(Date:10/19/2014)... , Deutschland, October 19, 2014 ... CRT-Fallstudien gefragt. Das Problem dabei ist, ... Informationen mit der Kompetenz zu teilen. ... und deshalb freuen wir uns umso mehr, dass ... gebeten, ihre Gepflogenheiten bei Kühlketten aufzuschreiben - mit ...
(Date:10/17/2014)... 17, 2014 With the recent changes ... has come across several challenges in creating and ... globalization.  The Medical Affairs ... to providing benchmarking and best practices across critical ... a service composed of three stages: 1) member-driven ...
(Date:10/17/2014)...  Hanger, Inc. (NYSE: HGR ) announced ... operations for the quarter ended September 30, 2014, on ... conference call to discuss these results is scheduled to ... 2014. Those wishing to participate should call 1-877-662-6095. A ... by dialing 1-855-859-2056 and referencing Conference ID # 91880739. ...
Breaking Medicine Technology:Vergleichsbericht zu Pharma-Kühlketten und CRT 2Early Key Findings from the Medical Affairs Consortium Research 2
... 2011 Carbylan BioSurgery, Inc. announced today the completion ... trial to evaluate the safety and effectiveness of two ... in patients with osteoarthritis of the knee.   Hydros ... combination products. "Hydros and Hydros TA are ...
... MAP Pharmaceuticals, Inc. (Nasdaq: MAPP ) today ... J.P. Morgan Healthcare Conference on Tuesday, January 11, 2011 at ... live webcast of the presentation will be available on the ... . A replay will also be available within 24 hours ...
Cached Medicine Technology:Carbylan BioSurgery Completes Enrollment in Key Clinical Feasibility Study of Hydros and Hydros TA in Patients With Pain From Knee Osteoarthritis; Core Patent Issued 2Carbylan BioSurgery Completes Enrollment in Key Clinical Feasibility Study of Hydros and Hydros TA in Patients With Pain From Knee Osteoarthritis; Core Patent Issued 3
... a patented Per-fit™ flexible PVC tube with ... cuff specifically designed to reduce insertion force ... anatomy. The kit s unique obturator/dilator design ... allowing for an easier transition through the ...
... Per-fit™ flexible PVC tube with a tapered ... designed to reduce insertion force and more ... kit s unique obturator/dilator design is engineered ... an easier transition through the tissue into ...
... Self-contained kits provide convenience and cost ... tracheostomy care trays offer a variety of ... and management of the tracheostomized patient. , ... trays, and trays with disposable inner cannula ...
... and cost control. , ,Our full ... variety of wound dressing components for the ... patient. , ,Tray configurations include full ... inner cannula for both rigid and flexible ...
Medicine Products: